APIC is a contract development and manufacturing organization (CDMO) that offers a wide range of services such as synthetic route design, pilot manufacturing, investigational medical manufacturing, and commercial production, by making full use of integrated processes that combine organic synthesis technologies and biotechnologies it has cultivated over many years
With this expansion, the Grand Island site provides redundant capacity to support global supply of media and further extends the site’s capabilities to produce the high-quality technology and materials needed for the development and commercial manufacturing of vaccines and biologic therapies
Despite the price increases for raw materials and logistics, EBITDA pre rose organically by 3.2% to € 1,782 million
Syngene's collaboration with Zoetis started in 2011
The expansion at CDMO facility in South Haven, will bring a new 4,000-gallon multi-use reactor train consisting of glass lined and stainless-steel materials of construction
Plant is part of the company's CAD $30 million capital investment in the site
The new facility will be delivered through an investment of approximately CHF 500 million and is expected to be completed in 2026
_256_384.jpg){kind=logo}
Meets the growing need for US-based API solubility and bioavailability enhancement services
The investment will enable the company to provide customers with a complete and integrated end-to-end solution
The Congress was held on June, 20-21, 2022 in Berlin, Germany
Subscribe To Our Newsletter & Stay Updated
